tiprankstipranks
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market
2616
CStone Pharmaceuticals
RESEARCH TOOLSreports
Want to see HK:2616 full AI Analyst Report?

CStone Pharmaceuticals (2616) Financial Statements

4 Followers

CStone Pharmaceuticals Financial Overview

CStone Pharmaceuticals's market cap is currently HK$14.67B. The company's EPS TTM is HK$-0.1375443288; its P/E ratio is -15.44; CStone Pharmaceuticals is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 262.61M¥ 407.20M¥ 463.84M¥ 481.36M¥ 243.72M
Gross Profit¥ 44.78M¥ 240.15M¥ 304.30M¥ 278.38M¥ 136.89M
Operating Income¥ -421.42M¥ -91.69M¥ -605.57M¥ -912.15M¥ -1.83B
EBITDA¥ -378.58M¥ -76.43M¥ -297.23M¥ -849.66M¥ -1.90B
Net Income¥ -425.69M¥ -91.21M¥ -367.23M¥ -902.68M¥ -1.92B
Balance Sheet
Cash & Short-Term Investments¥ 919.09M¥ 672.94M¥ 1.05B¥ 1.04B¥ 1.73B
Total Assets¥ 1.36B¥ 1.39B¥ 1.66B¥ 1.64B¥ 2.27B
Total Debt¥ 348.67M¥ 355.97M¥ 363.45M¥ 286.29M¥ 174.20M
Net Debt¥ -405.36M¥ -31.96M¥ -633.22M¥ -272.39M¥ -568.53M
Total Liabilities¥ 741.60M¥ 1.03B¥ 1.21B¥ 1.19B¥ 1.06B
Stockholders' Equity¥ 617.03M¥ 363.87M¥ 456.83M¥ 449.33M¥ 1.21B
Cash Flow
Free Cash Flow¥ -327.75M¥ -343.18M¥ -653.89M¥ -714.29M¥ -1.63B
Operating Cash Flow¥ -327.75M¥ -343.18M¥ -588.84M¥ -612.47M¥ -1.48B
Investing Cash Flow¥ 133.99M¥ -247.68M¥ 619.61M¥ 365.12M¥ -826.55M
Financing Cash Flow¥ 577.78M¥ -12.90M¥ 388.36M¥ 28.47M¥ 92.30M
Currency in CNY

CStone Pharmaceuticals Earnings and Revenue History

Income Statement >

CStone Pharmaceuticals Debt to Assets

Balance Sheet >

CStone Pharmaceuticals Cash Flow

Cash Flow >

CStone Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >